In addition to metabolism regulation, the expression level of HCAR3 is closely associated with colorectal cancer and breast cancer, hence, HCAR3 is recognized as a potential therapeutic target for these two types of cancer [10,11]. Here, HCAR3 is linked to breast carcinoma.